Cover Image

Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme

Saved in:
Bibliographic Details
Main Authors: Möhler, Markus (Author) , Ebert, Matthias (Author)
Format: Article (Journal)
Language:English
Published: December 2014
In: European journal of cancer
Year: 2014, Volume: 50, Issue: 18, Pages: 3125-3135
ISSN:1879-0852
DOI:10.1016/j.ejca.2014.09.013
Online Access:Verlag, Volltext: http://dx.doi.org/10.1016/j.ejca.2014.09.013
Get full text
Author Notes:M. Moehler, A. Maderer, C. Schimanski, S. Kanzler, U. Denzer, F.T. Kolligs, M.P. Ebert, A. Distelrath, M. Geissler, J. Trojan, M. Schütz, L. Berie, C. Sauvigny, F. Lammert, A. Lohse, M.M. Dollinger, U. Lindig, E.M. Duerr, N. Lubomierski, S. Zimmermann, D. Wachtlin, A.-K. Kaiser, S. Schadmand-Fischer, P.R. Galle, M. Woerns

MARC

LEADER 00000caa a2200000 c 4500
001 1550915851
003 DE-627
005 20220813102423.0
007 cr uuu---uuuuu
008 161213s2014 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ejca.2014.09.013  |2 doi 
035 |a (DE-627)1550915851 
035 |a (DE-576)480915857 
035 |a (DE-599)BSZ480915857 
035 |a (OCoLC)1340945539 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Möhler, Markus  |e VerfasserIn  |0 (DE-588)112161955X  |0 (DE-627)874401909  |0 (DE-576)480916063  |4 aut 
245 1 0 |a Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer  |b a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme  |c M. Moehler, A. Maderer, C. Schimanski, S. Kanzler, U. Denzer, F.T. Kolligs, M.P. Ebert, A. Distelrath, M. Geissler, J. Trojan, M. Schütz, L. Berie, C. Sauvigny, F. Lammert, A. Lohse, M.M. Dollinger, U. Lindig, E.M. Duerr, N. Lubomierski, S. Zimmermann, D. Wachtlin, A.-K. Kaiser, S. Schadmand-Fischer, P.R. Galle, M. Woerns 
264 1 |c December 2014 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am: 13.12.2016 
700 1 |a Ebert, Matthias  |d 1968-  |e VerfasserIn  |0 (DE-588)1030133522  |0 (DE-627)734827083  |0 (DE-576)377938432  |4 aut 
773 0 8 |i Enthalten in  |t European journal of cancer  |d Amsterdam [u.a.] : Elsevier, 1992  |g 50(2014), 18, Seite 3125-3135  |w (DE-627)266883400  |w (DE-600)1468190-0  |w (DE-576)090954173  |x 1879-0852  |7 nnas  |a Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme 
773 1 8 |g volume:50  |g year:2014  |g number:18  |g pages:3125-3135  |g extent:11  |a Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme 
856 4 0 |u http://dx.doi.org/10.1016/j.ejca.2014.09.013  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://dx.doi.org/10.1016/j.ejca.2014.09.013  |q application/pdf  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20161213 
993 |a Article 
994 |a 2014 
998 |g 1030133522  |a Ebert, Matthias  |m 1030133522:Ebert, Matthias  |d 60000  |d 61100  |e 60000PE1030133522  |e 61100PE1030133522  |k 0/60000/  |k 1/60000/61100/  |p 7 
999 |a KXP-PPN1550915851  |e 2948116465 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["M. Moehler, A. Maderer, C. Schimanski, S. Kanzler, U. Denzer, F.T. Kolligs, M.P. Ebert, A. Distelrath, M. Geissler, J. Trojan, M. Schütz, L. Berie, C. Sauvigny, F. Lammert, A. Lohse, M.M. Dollinger, U. Lindig, E.M. Duerr, N. Lubomierski, S. Zimmermann, D. Wachtlin, A.-K. Kaiser, S. Schadmand-Fischer, P.R. Galle, M. Woerns"]},"note":["Gesehen am: 13.12.2016"],"recId":"1550915851","origin":[{"dateIssuedDisp":"December 2014","dateIssuedKey":"2014"}],"id":{"eki":["1550915851"],"doi":["10.1016/j.ejca.2014.09.013"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"physDesc":[{"extent":"11 S."}],"person":[{"role":"aut","display":"Möhler, Markus","family":"Möhler","given":"Markus"},{"given":"Matthias","family":"Ebert","display":"Ebert, Matthias","role":"aut"}],"title":[{"title_sort":"Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer","title":"Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer","subtitle":"a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme"}],"relHost":[{"part":{"extent":"11","year":"2014","issue":"18","volume":"50","text":"50(2014), 18, Seite 3125-3135","pages":"3125-3135"},"title":[{"title_sort":"European journal of cancer","title":"European journal of cancer"}],"titleAlt":[{"title":"EJC online"}],"corporate":[{"display":"European Organization for Research on Treatment of Cancer","role":"isb"},{"display":"European Association for Cancer Research","role":"isb"},{"display":"European School of Oncology","role":"isb"}],"id":{"issn":["1879-0852"],"zdb":["1468190-0"],"eki":["266883400"]},"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"dateIssuedDisp":"1992-","publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]","dateIssuedKey":"1992","publisher":"Elsevier ; Pergamon Press"}],"recId":"266883400","pubHistory":["28.1992 -"],"note":["Gesehen am 21.03.24","Ungezählte Beil.: Supplement"],"disp":"Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programmeEuropean journal of cancer"}]} 
SRT |a MOEHLERMARGEMCITABIN2014 

Similar Items